LSAs (OXIS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLSAs (OXIS)
Drug Alias Namelipid soluble antioxidants (OXIS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionantioxidantNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusCardiovascular DiseasesAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGt Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGt Biopharma Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusCardiovascular DiseasesAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A